Skip to main content

Table 2 BCLC Staging. Group I, patients who were diagnosed histologically; Group II, patients who were diagnosed radiologically

From: Machine learning-based survival rate prediction of Korean hepatocellular carcinoma patients using multi-center data

BCLC staging Group I (n = 2920) Group II (n = 5562)
Stage 0 (n, %) 169(5.8) 445(8.0)
Stage A (n, %) 1,455(49.8) 1,966(35.3)
Stage B (n, %) 277(9.5) 613(11.0)
Stage C (n, %) 674(23.1) 1,737(31.2)
Stage D (n, %) 47(1.6) 194(3.5)
Undefined (n, %) 298(10.2) 607(10.9)